<?xml version="1.0" encoding="utf-8" ?> <rss version="2.0" xmlns:opensearch="http://a9.com/-/spec/opensearch/1.1/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom"> <channel> <title> <![CDATA[Cairo University Libraries portal Search for 'au:&quot;Yasser Ahmed Sallam,&quot;'with limit(s): 'suppress:false']]> </title> <!-- prettier-ignore-start --> <link> https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-search.pl?idx=&#38;q=au%3A%22Yasser%20Ahmed%20Sallam%2C%22&#38;sort_by=relevance&#38;format=rss </link> <!-- prettier-ignore-end --> <atom:link rel="self" type="application/rss+xml" href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-search.pl?idx=&#38;q=au%3A%22Yasser%20Ahmed%20Sallam%2C%22&#38;sort_by=relevance&#38;format=rss" /> <description> Search results for 'au:&quot;Yasser Ahmed Sallam,&quot;'with limit(s): 'suppress:false' at Cairo University Libraries portal </description> <opensearch:totalResults>10</opensearch:totalResults> <opensearch:startIndex>0</opensearch:startIndex> <opensearch:itemsPerPage>50</opensearch:itemsPerPage> <atom:link rel="search" type="application/opensearchdescription+xml" href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-search.pl?idx=&#38;q=au%3A%22Yasser%20Ahmed%20Sallam%2C%22&#38;sort_by=relevance&#38;format=opensearchdescription" /> <opensearch:Query role="request" searchTerms="idx%3D%26q%3Dau%253A%2522Yasser%2520Ahmed%2520Sallam%252C%2522suppress%3Afalse" startPage="" /> <item> <title> Multagent versus single agent chemotherapy in treatment of advanced cases of bilharzial bladder cancer / </title> <dc:identifier>ردمك: </dc:identifier> <!-- prettier-ignore-start --> <link>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=86056</link> <!-- prettier-ignore-end --> <description> <p> .<br /> 180P : 25cm.<br /> </p> <p> <a href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-reserve.pl?biblionumber=86056">Place hold on <em>Multagent versus single agent chemotherapy in treatment of advanced cases of bilharzial bladder cancer / </em></a> </p> </description> <guid>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=86056</guid> </item> <item> <title> Value of personalized chemotherapy dose adjustment in patients with advanced head and neck cancer / </title> <dc:identifier>ردمك: </dc:identifier> <!-- prettier-ignore-start --> <link>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=67007</link> <!-- prettier-ignore-end --> <description> <p> .<br /> 85 P. ; 25cm.<br /> </p> <p> <a href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-reserve.pl?biblionumber=67007">Place hold on <em>Value of personalized chemotherapy dose adjustment in patients with advanced head and neck cancer / </em></a> </p> </description> <guid>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=67007</guid> </item> <item> <title> Role of vascular endothelial growth factor (VEGF) in the prognosis and management of hepatocellular carcinoma HCC / </title> <dc:identifier>ردمك: </dc:identifier> <!-- prettier-ignore-start --> <link>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=54910</link> <!-- prettier-ignore-end --> <description> <p> .<br /> 104 P. ; 25cm.<br /> </p> <p> <a href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-reserve.pl?biblionumber=54910">Place hold on <em>Role of vascular endothelial growth factor (VEGF) in the prognosis and management of hepatocellular carcinoma HCC / </em></a> </p> </description> <guid>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=54910</guid> </item> <item> <title> Clinicopathological characteristics, treatment and outcome of cholangiocarcinoma patients, single institutional experience / </title> <dc:identifier>ردمك: </dc:identifier> <!-- prettier-ignore-start --> <link>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=80546</link> <!-- prettier-ignore-end --> <description> <p> .<br /> 135 P. : 25cm.<br /> </p> <p> <a href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-reserve.pl?biblionumber=80546">Place hold on <em>Clinicopathological characteristics, treatment and outcome of cholangiocarcinoma patients, single institutional experience / </em></a> </p> </description> <guid>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=80546</guid> </item> <item> <title> Surgical management of female breast cancer patients after neoadjuvant systemic therapy for Invasive ductal versus invasive lobular carcinoma / </title> <dc:identifier>ردمك: </dc:identifier> <!-- prettier-ignore-start --> <link>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=67449</link> <!-- prettier-ignore-end --> <description> <p> .<br /> 136 P. : 25cm.<br /> </p> <p> <a href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-reserve.pl?biblionumber=67449">Place hold on <em>Surgical management of female breast cancer patients after neoadjuvant systemic therapy for Invasive ductal versus invasive lobular carcinoma / </em></a> </p> </description> <guid>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=67449</guid> </item> <item> <title> Chemotherapy induced ovarian failure after adjuvant treatment for early breast cancer : National Cancer Institute experience / </title> <dc:identifier>ردمك: </dc:identifier> <!-- prettier-ignore-start --> <link>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=50932</link> <!-- prettier-ignore-end --> <description> <p> .<br /> 138 P. : 25cm.<br /> </p> <p> <a href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-reserve.pl?biblionumber=50932">Place hold on <em>Chemotherapy induced ovarian failure after adjuvant treatment for early breast cancer : </em></a> </p> </description> <guid>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=50932</guid> </item> <item> <title> FMS like tyrosine kinase 3 (FLT3) gene mutations ill acute myeloid leukemia (AML) in patients with low or intermediate risk karyotypes / </title> <dc:identifier>ردمك: </dc:identifier> <!-- prettier-ignore-start --> <link>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=30325</link> <!-- prettier-ignore-end --> <description> <p> .<br /> 217P. : 25cm.<br /> </p> <p> <a href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-reserve.pl?biblionumber=30325">Place hold on <em>FMS like tyrosine kinase 3 (FLT3) gene mutations ill acute myeloid leukemia (AML) in patients with low or intermediate risk karyotypes / </em></a> </p> </description> <guid>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=30325</guid> </item> <item> <title> Response criteria to induction chemotherapy as a prognostic factor for adult acute myeloid leukemia : Retrospective study of national cancer institute cases of year, 2009. / </title> <dc:identifier>ردمك: </dc:identifier> <!-- prettier-ignore-start --> <link>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=48047</link> <!-- prettier-ignore-end --> <description> <p> .<br /> 165 P. ; 25cm.<br /> </p> <p> <a href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-reserve.pl?biblionumber=48047">Place hold on <em>Response criteria to induction chemotherapy as a prognostic factor for adult acute myeloid leukemia : </em></a> </p> </description> <guid>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=48047</guid> </item> <item> <title> Second Malignancy After Cancer Treatment / </title> <dc:identifier>ردمك: </dc:identifier> <!-- prettier-ignore-start --> <link>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=178983</link> <!-- prettier-ignore-end --> <description> <p> 1995 .<br /> 156 Leaves 30 cm. + .<br /> </p> <p> <a href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-reserve.pl?biblionumber=178983">Place hold on <em>Second Malignancy After Cancer Treatment /</em></a> </p> </description> <guid>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=178983</guid> </item> <item> <title> Utilization of serial circulating tumor DNA analysis as a guide for the duration of adjuvant chemotherapy in stage III colon cancer / </title> <dc:identifier>ردمك: </dc:identifier> <!-- prettier-ignore-start --> <link>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=176758</link> <!-- prettier-ignore-end --> <description> <p> 2025 .<br /> 97 pages : 25 cm. + .<br /> </p> <p> <a href="https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-reserve.pl?biblionumber=176758">Place hold on <em>Utilization of serial circulating tumor DNA analysis as a guide for the duration of adjuvant chemotherapy in stage III colon cancer /</em></a> </p> </description> <guid>https://lis.cl.cu.edu.eg/cgi-bin/koha/opac-detail.pl?biblionumber=176758</guid> </item> </channel> </rss>
